Literature DB >> 26720796

Complement Propriety and Conspiracy in Nanomedicine: Perspective and a Hypothesis.

Seyed Moein Moghimi1.   

Abstract

The complement system is the first line of body's defense against intruders and it acts as a functional bridge between innate and adaptive arms of the immune system. This commentary examines the key roles of complement activation in response to nanomedicine administration, including nucleic acid complexes. These comprise beneficial (eg, adjuvanticity) as well as adverse effects (eg, infusion-related reactions). Pigs (and sheep) are often used as predictive models of nanomedicine-mediated infusion-related reactions in humans. The validity of these models in relation to human responses is questioned, and an alternative hypothesis is presented.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26720796     DOI: 10.1089/nat.2015.0587

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  4 in total

1.  Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes.

Authors:  Peter Popp Wibroe; Aaron C Anselmo; Per H Nilsson; Apoorva Sarode; Vivek Gupta; Rudolf Urbanics; Janos Szebeni; Alan Christy Hunter; Samir Mitragotri; Tom Eirik Mollnes; Seyed Moein Moghimi
Journal:  Nat Nanotechnol       Date:  2017-04-10       Impact factor: 39.213

Review 2.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

Review 3.  Polyplex Evolution: Understanding Biology, Optimizing Performance.

Authors:  Arnaldur Hall; Ulrich Lächelt; Jiri Bartek; Ernst Wagner; Seyed Moein Moghimi
Journal:  Mol Ther       Date:  2017-03-06       Impact factor: 11.454

4.  Kupffer cell release of platelet activating factor drives dose limiting toxicities of nucleic acid nanocarriers.

Authors:  Meredith A Jackson; Shrusti S Patel; Fang Yu; Matthew A Cottam; Evan B Glass; Ella N Hoogenboezem; R Brock Fletcher; Bryan R Dollinger; Prarthana Patil; Danielle D Liu; Isom B Kelly; Sean K Bedingfield; Allyson R King; Rachel E Miles; Alyssa M Hasty; Todd D Giorgio; Craig L Duvall
Journal:  Biomaterials       Date:  2020-11-23       Impact factor: 12.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.